MTOR and neoplasm: We have shown that propranolol-mediated perturbations in mitochondrial metabolism sensitize tumor cells to glucose deprivation, and that tumor cell metabolism and mTOR signaling are attenuated when propranolol is combined with the glycolytic inhibitor DCA.